VVUS Related Rumors
-
VIVUS (VVUS) Volatile on Comments of Big Phrama Interest
-
Vivus (VVUS) Spikes on Partnership Discussions
-
QVT Financial Lowers Stake in Vivus, Inc. (VVUS) to 8.3%; Says Company Should Be Sold
-
Arena Pharmaceuticals (ARNA) Jumps on Takeover Speculation
-
Arena Pharma (ARNA) Higher as M&A Chatter Heats Up
-
Human Genome (HGSI) Trades Well Above GSK Offer, Other Biotechs See Action
-
VIVUS (VVUS) Could Be Bought For Up to $40/Share
-
Leerink Swann Upgrades Vivus (VVUS) to Outperform; Becoming A More Attractive Asset For Big Pharma After Qnexa Approval
-
Biotech M&A Will Be In Focus in 2012 - Goldman
-
Wall Street Hubbub 9/10: Computer Sciences (CSC) Seen As Great LBO Target, China-Biotics (CHBT) Addresses "Rumors", Hartford Financial (HIG) Up on Buyout Chatter
-
Wall Street Hubbub 7/15: JPMorgan's Earnings Quality "Weak", BP On Verge of Asset Sale, AIG's Benmosche Makes More Waves, iPhone 4 Fiasco
-
VIVUS's (VVUS) FDA Panel Meeting Not Delayed
-
VIVUS (VVUS) Drops On Rumors of Panel Delay
-
Wall Street Hubbub 7/14: iPhone 4 Recall, Penthouse-for-Playboy, BP's New Cap Is No Savior, KKR IPO, Treasury Weighs Citi (C) Options
-
Biotech Takeover Buzz Continues (VVUS, DNDN, HGSI, IMMU, CEPH)
Back to VVUS Stock Lookup
